• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胎儿和母体内脐带血的血脂在宫内生长受限中的变化。

Maternal and fetal cord blood lipids in intrauterine growth restriction.

机构信息

Department of Obstetrics and Gynecology of the University Hospital of the RWTH Aachen, Germany.

出版信息

J Perinat Med. 2012 Jan 6;40(3):287-96. doi: 10.1515/jpm.2011.135.

DOI:10.1515/jpm.2011.135
PMID:22505508
Abstract

AIM

Small for gestational age neonates (SGA) could be subdivided into two groups according to the underlying causes leading to low birth weight. Intrauterine growth restriction (IUGR) is a pathologic condition with diminished growth velocity and fetal compromised well-being, while non-growth restricted SGA neonates are constitutionally (genetically determined) small. Antenatal sonographic measurements are used to differentiate these two subgroups. Maternal metabolic changes contribute to the pathogenesis of IUGR. A disturbed lipid metabolism and cholesterol supply might affect the fetus, with consequences for fetal programming of cardiovascular diseases. We evaluated fetal serum lipids and hypothesized a more atherogenic lipoprotein profile in IUGR fetuses.

METHODS

Umbilical cord serum lipids and oxidative modified, low-density lipoprotein (oxLDL) concentrations were measured by colorimetric enzymatic measurements, or by ELISA. Values of IUGR (n=36) and constitutionally small for gestational age neonates (SGA, n=22) were compared with those of healthy, adequate for gestational age, born neonates (CN, n=97). SAS-statistic software was used and two-way ANOVA was adjusted for gestational age at delivery.

RESULTS

Fetal high-density lipoprotein cholesterol (HDL-C) and total cholesterol (TC) concentrations were found to be lower in the IUGR compared to the CN and SGA groups (HDL-C: P<0.001, TC: P<0.01). Atherogenic indices, including the oxLDL/LDL-C ratio, were increased in the IUGR compared to the CN group (oxLDL/LDL-C ratio: P<0.001).

CONCLUSION

Our results support the hypothesis of a disturbed cholesterol supply in IUGR fetuses. Born SGA has been shown to be a risk factor for developing cardiovascular disease later in life. Since HDL-C has anti-inflammatory properties, a reduced HDL-C during fetal development, and an increase in atherogenic indices, might provide a link to this observation in IUGR fetuses.

摘要

目的

根据导致低出生体重的潜在原因,小胎龄儿(SGA)可分为两组。宫内生长受限(IUGR)是一种生长速度减慢、胎儿健康受损的病理状态,而非生长受限的 SGA 新生儿则是先天(遗传决定)的小。产前超声测量用于区分这两个亚组。母体代谢变化有助于 IUGR 的发病机制。脂质代谢紊乱和胆固醇供应可能会影响胎儿,对胎儿心血管疾病的编程产生影响。我们评估了胎儿血清脂质,并假设 IUGR 胎儿中存在更具动脉粥样硬化倾向的脂蛋白谱。

方法

通过比色酶测定法或 ELISA 测定脐带血清脂质和氧化修饰的低密度脂蛋白(oxLDL)浓度。将 IUGR(n=36)和胎龄与体重相称的小胎龄儿(SGA,n=22)的数值与健康、胎龄适宜的出生儿(CN,n=97)的数值进行比较。使用 SAS 统计软件,并对分娩时的胎龄进行双因素方差分析调整。

结果

与 CN 和 SGA 组相比,IUGR 组胎儿高密度脂蛋白胆固醇(HDL-C)和总胆固醇(TC)浓度较低(HDL-C:P<0.001,TC:P<0.01)。与 CN 组相比,IUGR 组的致动脉粥样硬化指数(包括 oxLDL/LDL-C 比值)升高(oxLDL/LDL-C 比值:P<0.001)。

结论

我们的结果支持 IUGR 胎儿胆固醇供应紊乱的假设。已证明出生时的 SGA 是以后发生心血管疾病的危险因素。由于 HDL-C 具有抗炎特性,因此胎儿发育期间 HDL-C 减少和致动脉粥样硬化指数增加可能为 IUGR 胎儿的这一观察结果提供了联系。

相似文献

1
Maternal and fetal cord blood lipids in intrauterine growth restriction.胎儿和母体内脐带血的血脂在宫内生长受限中的变化。
J Perinat Med. 2012 Jan 6;40(3):287-96. doi: 10.1515/jpm.2011.135.
2
Fetal cord plasma lipoprotein status in uncomplicated human pregnancies and in pregnancies complicated by pre-eclampsia and intrauterine growth restriction.正常妊娠以及合并子痫前期和胎儿生长受限的妊娠中胎儿脐血浆脂蛋白状态
Atherosclerosis. 2004 Sep;176(1):181-7. doi: 10.1016/j.atherosclerosis.2004.04.026.
3
Cord blood lipid profile and associated factors: baseline data of a birth cohort study.脐带血脂谱及相关因素:一项出生队列研究的基线数据
Paediatr Perinat Epidemiol. 2007 Nov;21(6):518-24. doi: 10.1111/j.1365-3016.2007.00870.x.
4
The evaluation of the oxidative state of low-density lipoproteins in intrauterine growth restriction and preeclampsia.宫内生长受限和子痫前期中低密度脂蛋白氧化状态的评估。
Hypertens Pregnancy. 2012;31(1):156-65. doi: 10.3109/10641955.2010.544805. Epub 2011 Jan 20.
5
Newborns of pre-eclamptic women: a biochemical difference present in utero.子痫前期孕妇的新生儿:子宫内存在的生化差异。
Acta Obstet Gynecol Scand. 2006;85(10):1172-8. doi: 10.1080/00016340600697272.
6
Serum adiponectin levels, insulin resistance, and lipid profile in children born small for gestational age are affected by the severity of growth retardation at birth.小于胎龄儿血清脂联素水平、胰岛素抵抗和血脂谱受出生时生长迟缓严重程度的影响。
Eur J Endocrinol. 2007 Feb;156(2):271-7. doi: 10.1530/eje.1.02337.
7
The concentration of lipids, lipoproteins and apolipoproteins in cord blood serum of newborns in the course of intrauterine period.宫内期新生儿脐带血血清中脂质、脂蛋白和载脂蛋白的浓度。
Ann Univ Mariae Curie Sklodowska Med. 2003;58(2):25-32.
8
Plasma lipids and lipoproteins during pregnancy and related pregnancy outcomes.孕期血浆脂质和脂蛋白及其与妊娠结局的关系。
Arch Gynecol Obstet. 2013 Jul;288(1):49-55. doi: 10.1007/s00404-013-2750-y. Epub 2013 Feb 12.
9
Mass spectrometric profiling of cord blood serum proteomes to distinguish infants with intrauterine growth restriction from those who are small for gestational age and from control individuals.应用质谱分析技术对脐血血清蛋白质组进行分析,以区分宫内发育受限儿、小于胎龄儿和正常儿。
Transl Res. 2014 Jul;164(1):57-69. doi: 10.1016/j.trsl.2013.12.003. Epub 2013 Dec 10.
10
Maternal serum activin A levels in association with intrauterine fetal growth restriction.母血清激活素A水平与胎儿宫内生长受限的关系
BJOG. 2003 Mar;110(3):306-10.

引用本文的文献

1
Impact of Maternal Pre-Pregnancy Underweight on Cord Blood Metabolome: An Analysis of the Population-Based Survey of Neonates in Pomerania (SNiP).母体孕前体重不足对脐血代谢组的影响:波美拉尼亚新生儿人群调查(SNiP)分析。
Int J Mol Sci. 2024 Jul 10;25(14):7552. doi: 10.3390/ijms25147552.
2
COVID-19 Infection during Pregnancy: Disruptions in Lipid Metabolism and Implications for Newborn Health.COVID-19 感染与妊娠:脂代谢紊乱及其对新生儿健康的影响。
Int J Mol Sci. 2023 Sep 7;24(18):13787. doi: 10.3390/ijms241813787.
3
Dousing the flame: reviewing the mechanisms of inflammatory programming during stress-induced intrauterine growth restriction and the potential for ω-3 polyunsaturated fatty acid intervention.
扑灭炎症之火:回顾应激诱导的宫内生长受限期间炎症编程的机制以及ω-3多不饱和脂肪酸干预的潜力。
Front Physiol. 2023 Sep 1;14:1250134. doi: 10.3389/fphys.2023.1250134. eCollection 2023.
4
Cord blood triglyceride and total cholesterol in preterm and term neonates: reference values and associated factors from the Japan Environment and Children's Study.早产儿和足月新生儿脐带血甘油三酯和总胆固醇:来自日本环境与儿童研究的参考值及其相关因素。
Eur J Pediatr. 2023 Oct;182(10):4547-4556. doi: 10.1007/s00431-023-05118-6. Epub 2023 Jul 31.
5
Reduced adipose tissue in growth-restricted fetuses using quantitative analysis of magnetic resonance images.生长受限胎儿磁共振图像定量分析脂肪组织减少。
Eur Radiol. 2023 Dec;33(12):9194-9202. doi: 10.1007/s00330-023-09855-y. Epub 2023 Jun 30.
6
Association between maternal lipid levels during pregnancy and delivery of small for gestational age: A systematic review and meta-analysis.孕期母体血脂水平与小于胎龄儿分娩之间的关联:一项系统评价和荟萃分析。
Front Pediatr. 2022 Oct 6;10:934505. doi: 10.3389/fped.2022.934505. eCollection 2022.
7
Maternal lipid profile in pregnancy and embryonic size: a population-based prospective cohort study.妊娠母体血脂谱与胚胎大小:基于人群的前瞻性队列研究。
BMC Pregnancy Childbirth. 2022 Apr 18;22(1):333. doi: 10.1186/s12884-022-04647-6.
8
Hypertensive disease, preterm birth, fetal growth restriction and chronic inflammatory disorders of the placenta: experiences in a single institution with a standardized protocol of investigation.高血压疾病、早产、胎儿生长受限和胎盘慢性炎症性疾病:单中心应用标准化调查方案的经验。
Arch Gynecol Obstet. 2022 Aug;306(2):337-347. doi: 10.1007/s00404-021-06293-3. Epub 2021 Oct 24.
9
Cord serum metabolome and birth weight in patients with gestational diabetes treated with metformin, insulin, or diet alone.脐带血清代谢组学与单纯饮食、二甲双胍或胰岛素治疗的妊娠期糖尿病患者的出生体重。
BMJ Open Diabetes Res Care. 2021 May;9(1). doi: 10.1136/bmjdrc-2020-002022.
10
apoA2 correlates to gestational age with decreased apolipoproteins A2, C1, C3 and E in gestational diabetes.载脂蛋白 A2 与妊娠期糖尿病患者的胎龄相关,且与载脂蛋白 A2、C1、C3 和 E 降低有关。
BMJ Open Diabetes Res Care. 2021 Mar;9(1). doi: 10.1136/bmjdrc-2020-001925.